0000899243-20-005093.txt : 20200219 0000899243-20-005093.hdr.sgml : 20200219 20200219180136 ACCESSION NUMBER: 0000899243-20-005093 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200214 FILED AS OF DATE: 20200219 DATE AS OF CHANGE: 20200219 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mansbach Harry H CENTRAL INDEX KEY: 0001300615 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39122 FILM NUMBER: 20631640 MAIL ADDRESS: STREET 1: 15241 BARRANCA PKWY CITY: IRVINE STATE: CA ZIP: 92618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: 89bio, Inc. CENTRAL INDEX KEY: 0001785173 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831114349 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 535 MISSION STREET STREET 2: 14TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: 4155004614 MAIL ADDRESS: STREET 1: 535 MISSION STREET STREET 2: 14TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-14 0 0001785173 89bio, Inc. ETNB 0001300615 Mansbach Harry H C/O 89BIO, INC. 142 SANSOME STREET, 2ND FLOOR SAN FRANCISCO CA 94104 0 1 0 0 Chief Medical Officer Stock Option (Right to Buy) 32.50 2020-02-14 4 A 0 45000 0.00 A 2030-02-14 Common Stock 45000 45000 D This option represents a right to purchase a total of 45,000 shares of the Issuer's Common Stock, one quarter of which will vest on February 14, 2021, with the remaining three quarters vesting in equal quarterly installments over the following three years. /s/ Ryan A. Murr, as attorney-in-fact for Harry H. Mansbach 2020-02-19